Healthcare ServicesCompany
Asuragen - Pancreas Cancer Test Assets Ownership
Who owns Asuragen - Pancreas Cancer Test Assets?
Asuragen - Pancreas Cancer Test Assets is owned by Interpace Biosciences. It was acquired on August 13, 2014.
Asuragen - Pancreas Cancer Test Assets Business Overview
Where is Asuragen - Pancreas Cancer Test Assets headquartered?
Asuragen - Pancreas Cancer Test Assets is headquartered in United States.
What sector is Asuragen - Pancreas Cancer Test Assets in?
Asuragen - Pancreas Cancer Test Assets is a healthcare services company.
Healthcare Services M&A Summary in 2014
Out of 60 sectors in the Mergr database, healthcare services ranked 5 in number of deals in 2014. The largest healthcare services acquisition in 2014 was CareFusion - which was acquired by Becton Dickinson for $12.2B.
Join Mergr to view all 363 acquisitions of healthcare services companies in 2014, including 48 acquisitions by private equity firms, and 315 by strategics.